These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31667502)

  • 1. Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China.
    Jian L; Xiujian S; Yuangang Y; Yan X; Lianchao Y; Duthie MS; Yan W
    Trans R Soc Trop Med Hyg; 2020 Feb; 114(3):193-199. PubMed ID: 31667502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of immunoglobulin isotypes against LID-1 and NDO-LID for, particularly IgG1, confirming the diagnosis of multibacillary leprosy.
    Marçal PHF; Fraga LAO; Mattos AMM; Menegati L; Coelho ADCO; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Mem Inst Oswaldo Cruz; 2018; 113(5):e170467. PubMed ID: 29513821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China.
    Chen X; You YG; Yuan YH; Yuan LC; Zhang Y; Yan W
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006777. PubMed ID: 30248098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region.
    da Conceição Oliveira Coelho Fabri A; Carvalho AP; Araujo S; Goulart LR; de Mattos AM; Teixeira HC; Goulart IM; Duthie MS; Correa-Oliveira R; Lana FC
    BMC Infect Dis; 2015 May; 15():218. PubMed ID: 26021317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil.
    Leturiondo AL; Noronha AB; do Nascimento MOO; Ferreira CO; Rodrigues FDC; Moraes MO; Talhari C
    BMC Infect Dis; 2019 Jan; 19(1):22. PubMed ID: 30616580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO.
    Amorim FM; Nobre ML; Ferreira LC; Nascimento LS; Miranda AM; Monteiro GR; Dupnik KM; Duthie MS; Reed SG; Jeronimo SM
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004934. PubMed ID: 27658042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
    Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and advances in serological and molecular tests to aid leprosy diagnosis.
    Lopes-Luz L; Saavedra DP; Fogaça MBT; Bührer-Sékula S; Stefani MMA
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2083-2094. PubMed ID: 38059475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Enzyme-Linked Immunosorbent Assay Using Either Natural Octyl Disaccharide-Leprosy IDRI Diagnostic or Phenolic Glycolipid-I Antigens for the Detection of Leprosy Patients in Colombia.
    Muñoz M; Beltrán-Alzate JC; Duthie MS; Serrano-Coll H; Cardona-Castro N
    Am J Trop Med Hyg; 2018 Jan; 98(1):274-277. PubMed ID: 29141725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgA Antibodies Specific to
    Silva KKPE; de Oliveira EE; Elias CMM; Pereira IE; Pinheiro RO; Sarno EN; Duthie MS; Teixeira HC
    Front Med (Lausanne); 2021; 8():698495. PubMed ID: 34447763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.
    Serrano-Coll H; Muñoz M; Camilo Beltrán J; Duthie MS; Cardona-Castro N
    Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):125-131. PubMed ID: 28633333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology.
    Paula Vaz Cardoso L; Dias RF; Freitas AA; Hungria EM; Oliveira RM; Collovati M; Reed SG; Duthie MS; Martins Araújo Stefani M
    BMC Infect Dis; 2013 Oct; 13():497. PubMed ID: 24152601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High seropositivity against NDO-LID in a group of household contacts of leprosy patients. Are we close to leprosy elimination in Colombia?
    Serrano-Coll H; Muñoz M; Beltrán JC; Cardona-Castro N
    Pathog Glob Health; 2023 Dec; 117(8):727-734. PubMed ID: 37231779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpectedly high leprosy seroprevalence detected using a random surveillance strategy in midwestern Brazil: A comparison of ELISA and a rapid diagnostic test.
    Frade MA; de Paula NA; Gomes CM; Vernal S; Bernardes Filho F; Lugão HB; de Abreu MM; Botini P; Duthie MS; Spencer JS; Soares RC; Foss NT
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005375. PubMed ID: 28231244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.
    Hungria EM; Oliveira RM; Souza AL; Costa MB; Souza VN; Silva EA; Moreno FR; Nogueira ME; Costa MR; Silva SM; Bührer-Sékula S; Reed SG; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():104-11. PubMed ID: 23283461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host immune responses induced by specific Mycobacterium leprae antigens in an overnight whole-blood assay correlate with the diagnosis of paucibacillary leprosy patients in China.
    Chen X; You YG; Yuan YH; Yuan LC; Wen Y
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007318. PubMed ID: 31017900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
    Douglas JT; Steven LM; Hirsch DS; Fujiwara T; Nelson KE; Madarang MG; Cellona RV
    Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of protein antigens for early serological diagnosis of leprosy.
    Duthie MS; Goto W; Ireton GC; Reece ST; Cardoso LP; Martelli CM; Stefani MM; Nakatani M; de Jesus RC; Netto EM; Balagon MV; Tan E; Gelber RH; Maeda Y; Makino M; Hoft D; Reed SG
    Clin Vaccine Immunol; 2007 Nov; 14(11):1400-8. PubMed ID: 17898185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy.
    Duthie MS; Balagon MF; Maghanoy A; Orcullo FM; Cang M; Dias RF; Collovati M; Reed SG
    J Clin Microbiol; 2014 Feb; 52(2):613-9. PubMed ID: 24478496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.